1 asset in Peroxisomal Acyl-CoA Oxidase Deficiency

Therapeutic assets addressing Peroxisomal Acyl-CoA Oxidase Deficiency, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cald Hr-D Peroxisomal Acyl-CoA Oxidase Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)